Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-081093

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Christopher Haqq
Officer — Chief Medical Officer
Period of report
Nov 16, 2015
Accepted (ET)
Nov 18, 2015 · 6:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Nov 16, 2015M829$0.00A241,719D
Common StockF2,F3holding———17,312ISee footnote
Common StockF2,F4holding———2,688ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF5,F6,F7—Nov 16, 2015M829D——Common Stock8297,186D

Explanation of responses